Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Biosci Rep ; 36(6)2016 12.
Article in English | MEDLINE | ID: mdl-27834666

ABSTRACT

An in vitro system that supports primordial germ cells (PGCs) survival and proliferation is useful for enhancement of these cells and efficient transplantation in infertility disorders. One approach is cultivation of PGCs under proper conditions that allow self-renewal and proliferation of PGCs. For this purpose, we compared the effects of different concentrations of retinoic acid (RA), and the effect of PGCs co-culture (Co-C) with SIM mouse embryo-derived thioguanine- and ouabain-resistant (STO) cells on the proliferation of embryonic stem cells (ESCs)-derived PGCs. One-day-old embryoid body (EB) was cultured for 4 days in simple culture system in the presence of 5 ng/ml bone morphogenetic protein-4 (BMP4) (SCB group) for PGC induction. For PGC enrichment, ESCs-derived germ cells were cultured for 7 days in the presence of different doses (0-5  µM) of RA, both in the simple and STO Co-C systems. At the end of the culture period, viability and proliferation rates were assessed and expression of mouse vasa homologue (Mvh),  α6 integrin,  ß1 integrin, stimulated by retinoic acid 8 (Stra8) and piwi (Drosophila)-like 2 (Piwil2) was evaluated using quantitative PCR. Also, the inductive effects were investigated immunocytochemically with Mvh and cadherin1 (CDH1) on the selected groups. Immunocytochemistry/PCR results showed higher expression of Mvh, the PGC-specific marker, in 3  µM RA concentrations on the top of the STO feeder layer. Meanwhile, assessment of the Stra8 mRNA and CDH1 protein, the specific makers for spermatogonia, showed no significant differences between groups. Based on the results, it seems that in the presence of 3 µM RA on top of the STO feeder layer cells, the majority of the cells transdifferentiated into germ cells were PGCs.


Subject(s)
Cell Proliferation/drug effects , Cell Transdifferentiation/drug effects , Embryonic Stem Cells/drug effects , Spermatogonia/cytology , Tretinoin/pharmacology , Adaptor Proteins, Signal Transducing/drug effects , Adaptor Proteins, Signal Transducing/genetics , Adaptor Proteins, Signal Transducing/metabolism , Animals , Argonaute Proteins/drug effects , Argonaute Proteins/genetics , Argonaute Proteins/metabolism , Biomarkers/metabolism , Bone Morphogenetic Protein 4/metabolism , Cdh1 Proteins/drug effects , Cdh1 Proteins/metabolism , Cell Differentiation , Cell Survival/drug effects , Cells, Cultured , Coculture Techniques , DEAD-box RNA Helicases/drug effects , DEAD-box RNA Helicases/genetics , DEAD-box RNA Helicases/metabolism , Embryonic Stem Cells/cytology , Immunohistochemistry , Integrin alpha6beta1/drug effects , Integrin alpha6beta1/genetics , Integrin alpha6beta1/metabolism , Male , Mice , Spermatogonia/metabolism , Transcriptome
2.
Reproduction ; 149(4): 329-38, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25737569

ABSTRACT

Prospermatogonia transition to type A spermatogonia, which provide the source for the spermatogonial stem cell (SSC) pool. A percentage of these type A spermatogonia then differentiate to enter meiosis as spermatocytes by ∼P10. It is currently unclear as to when these distinct populations are initially formed in the neonatal testis, and when the expression of markers both characteristic of and required for the adult undifferentiated and differentiating states is established. In this study, we compared expression of known spermatogonial cell fate markers during normal development and in response to the differentiation signal provided by retinoic acid (RA). We found that some markers for the undifferentiated state (ZBTB16/PLZF and CDH1) were expressed in nearly all spermatogonia from P1 through P7. In contrast, differentiation markers (STRA8 and KIT) appeared in a subset of spermatogonia at P4, coincident with the onset of RA signaling. GFRA1, which was present in nearly all prospermatogonia at P1, was only retained in STRA8/KIT- spermatogonia. From P4 through P10, there was a great deal of heterogeneity in the male germ cell population in terms of expression of markers, as markers characteristic of the undifferentiated (except GFRA1) and differentiating states were co-expressed through this interval. After P10, these fate markers diverged to mark distinct populations of undifferentiated and differentiating spermatogonia, and this pattern was maintained in juvenile (P18) and adult (P>60) testes. Taken together, these results reveal that the spermatogonia population is heterogeneous during the first wave of spermatogenesis, and indicate that neonatal spermatogonia may not serve as an ideal substitute for studying the function of adult spermatogonia.


Subject(s)
Biomarkers/metabolism , Cell Differentiation/physiology , Spermatogenesis/physiology , Spermatogonia/cytology , Testis/cytology , Animals , Animals, Newborn , Antineoplastic Agents/pharmacology , Cdh1 Proteins/drug effects , Cell Differentiation/drug effects , Immunoenzyme Techniques , Kruppel-Like Transcription Factors/drug effects , Male , Mice , Mice, Inbred C57BL , Promyelocytic Leukemia Zinc Finger Protein , Proto-Oncogene Proteins c-kit/drug effects , Spermatogenesis/drug effects , Spermatogonia/drug effects , Spermatogonia/metabolism , Testis/drug effects , Testis/metabolism , Tretinoin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...